SCHEMBL67726

SCHEMBL67726

CC1(C)OC2[C@@H](CO)O[C@@H](n3cc(I)c4c(N)ncnc43)[C@H]2O1

nearest known ligand 0.66

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PI4KA P42356 1/20 0.66
PI4K2B Q8TCG2 1/20 0.66
PI4K2A Q9BTU6 1/20 0.66
PI4KB Q9UBF8 1/20 0.66
ADK P55263 14/20 0.60
SLC29A1 Q99808 1/20 0.50
HASPIN Q8TF76 1/20 0.49
DOT1L Q8TEK3 1/20 0.48
NPC1 O15118 1/20 0.48
GALR3 O60755 1/20 0.48
S1PR4 O95977 1/20 0.48
ALDH1A1 P00352 1/20 0.48
MAPT P10636 1/20 0.48
S1PR1 P21453 1/20 0.48
HTT P42858 1/20 0.48
RAB9A P51151 1/20 0.48
PAX8 Q06710 1/20 0.48
STING1 Q86WV6 1/20 0.47
RXFP1 Q9HBX9 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL90988 1.00 PI4KA (0.66) PI4KAPI4K2BPI4K2API4KBADK
SCHEMBL60676 1.00 PI4KA (0.66) PI4KAPI4K2BPI4K2API4KBADK
SCHEMBL18297604 0.96 ADK (0.62) PI4KAPI4K2BPI4K2API4KBADK
Iodotubercidin SCHEMBL18297690 0.94 ADK (0.67) PI4KAPI4K2BPI4K2API4KBADK
SCHEMBL18297471 0.91 ADK (0.65) PI4KAPI4K2BPI4K2API4KBADK
SCHEMBL90990 0.88 ADK (0.67) PI4KAPI4K2BPI4K2API4KBADK
SCHEMBL67029 0.88 ADK (0.67) PI4KAPI4K2BPI4K2API4KBADK
SCHEMBL60684 0.88 ADK (0.67) PI4KAPI4K2BPI4K2API4KBADK
SCHEMBL31526134 0.88 PI4KA (0.66) PI4KAPI4K2BPI4K2API4KBADK
SCHEMBL18571721 0.88 PI4KA (0.66) PI4KAPI4K2BPI4K2API4KBADK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8129106-B2 Sequence-specific detection of methylation in biomolecules Max-Planck-Geselischaft zur Forderung der Wissenschaften E.V. (DE) 2012-03-06 US disclosed
US-20110165564-A1 SEQUENCE-SPECIFIC DETECTION OF METHYLATION IN BIOMOLECULES MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110165564-A1 SEQUENCE-SPECIFIC DETECTION OF METHYLATION IN BIOMOLECULES DNMT1, MAT2B, AHCY PI4KA 4743/4885PI4K2B 4739/4885PI4K2A 4799/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.